- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02955875
Pharmaceutical Care Service in Diabetes (IMPACT4-DM)
2. november 2016 opdateret af: Jeong-Hyun Yoon, Pusan National University
Impact of Pharmaceutical Care Service for Type 2 Diabetes Mellitus Patients in Korea
The purpose of this study is to examine the effectiveness of pharmaceutical care service in the management of poorly controlled type 2 diabetes mellitus.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
257
Fase
- Ikke anvendelig
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
20 år til 75 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria: Patients who visit Endocrinology and Metabolism department of Pusan National University Hospital, are with type 2 diabetes mellitus, and meet one of the following criteria
- Who are diagnosed with type 2 diabetes mellitus for the first time
- Who need the education for medication or disease
- Who are with poorly controlled blood glucose
- Who have poor medication adherence
- Who have been hospitalized with diabetes complication or poorly controlled blood glucose
- Whose physician recommend the pharmaceutical care to them
Exclusion Criteria: Patients who meet one of the following criteria
- Who are with gestational diabetes
- Who are not able to respond to questionnaires
- Who are with severe condition such as cerebrovascular disease, mental disorder, and acquired immune deficiency syndrome
- Who are not able to be followed-up during 9 months in Pusan National University Hospital
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Sundhedstjenesteforskning
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Pharmaceutical care
Participants received systematically organized pharmaceutical care services, which were provided by pharmacists, in addition to the usual care.
The usual care includes traditional consultation with pharmacists as well as traditional medical services provided by physicians, nurses, and dietitian.
|
Outpatient drug history management, drug regimen review, patient counseling and education before and/or after physician evaluation on the day of facility visit
Andre navne:
|
|
Ingen indgriben: Usual care
Participants received the usual care, which includes traditional consultation with pharmacists as well as traditional medical services provided by physicians, nurses, and dietitian.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Medications knowledge at 9 months
Tidsramme: 9 months
|
Patients' knowledge about diabetes medications was measured by an instrument.
The instrument includes items such as the name of medication, mechanism of action, dosage, and side effects.
|
9 months
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
HbA1c level at 9 months
Tidsramme: 9 months
|
9 months
|
|
Random blood glucose level at 9 months
Tidsramme: 9 months
|
9 months
|
|
Blood pressure at 9 months
Tidsramme: 9 months
|
9 months
|
|
Cholesterol level at 9 months
Tidsramme: 9 months
|
9 months
|
|
Proportion of participants taking statins 9 months
Tidsramme: 9 months
|
9 months
|
|
Proportion of participants managing diabetes complications at 9 months
Tidsramme: 9 months
|
9 months
|
|
Morisky Medication Adherence Scale at 9 months
Tidsramme: 9 months
|
9 months
|
|
5-level version of the EQ-5D at 9 months
Tidsramme: 9 months
|
9 months
|
|
EQ Visual Analogue Scale at 9 months
Tidsramme: 9 months
|
9 months
|
|
Problem Areas In Diabetes-Korean questionnaire at 9 months
Tidsramme: 9 months
|
9 months
|
|
Patient Satisfaction Questionnaire-Korean at 9 months
Tidsramme: 9 months
|
9 months
|
|
Cost-effectiveness of pharmaceutical care at 9 months
Tidsramme: 9 months
|
9 months
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. januar 2015
Primær færdiggørelse (Faktiske)
1. maj 2016
Studieafslutning (Faktiske)
1. juni 2016
Datoer for studieregistrering
Først indsendt
26. oktober 2016
Først indsendt, der opfyldte QC-kriterier
2. november 2016
Først opslået (Skøn)
4. november 2016
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
4. november 2016
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
2. november 2016
Sidst verificeret
1. november 2016
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- PNU-2014-001
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .